3-Ethyl-8-((2-(4-(hydroxymethyl)piperidin-1-yl)benzyl)amino)-1,3-dihydro-2H-imidazo[4,5-g]quinazoline-2-thione

Catalog No. :
ACHFBI876
CAS No. :
220060-39-9
Molecular Formula :
C24H28N6OS
Molecular Weight :
448.60

IUPAC Name:3-Ethyl-8-((2-(4-(hydroxymethyl)piperidin-1-yl)benzyl)amino)-1,3-dihydro-2H-imidazo[4,5-g]quinazoline-2-thione

3-Ethyl-8-((2-(4-(hydroxymethyl)piperidin-1-yl)benzyl)amino)-1,3-dihydro-2H-imidazo[4,5-g]quinazoline-2-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Ethyl-8-((2-(4-(hydroxymethyl)piperidin-1-yl)benzyl)amino)-1,3-dihydro-2H-imidazo[4,5-g]quinazoline-2-thione
IUPAC Name3-Ethyl-8-((2-(4-(hydroxymethyl)piperidin-1-yl)benzyl)amino)-1,3-dihydro-2H-imidazo[4,5-g]quinazoline-2-thione
Molecular FormulaC24H28N6OS
Molecular Weight448.60
SMILESS=C1NC2=CC3=C(N=CN=C3C=C2N1CC)NCC4=CC=CC=C4N5CCC(CC5)CO
InChI KeyNMKUPEWPVORTPC-UHFFFAOYSA-N
SynonymKF31327;3-ethyl-8-[[2-[4-(hydroxymethyl)piperidin-1-yl]phenyl]methylamino]-1H-imidazo[4,5-g]quinazoline-2-thione;Thioquinapiperifil;2H-Imidazo[4,5-g]quinazoline-2-thione, 3-ethyl-1,3-dihydro-8-[[[2-[4-(hydroxymethyl)-1-piperidinyl]phenyl]methyl]amino]-;KF-31327 free base;Thioquinapiperfil
CAS No.220060-39-9

Synthetic Route by SureRoute

1. ACHFBI876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHFBI876 route product structure diagram
    ACHFBI876220060-39-9
Inquiry

2. ACHFBI876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEOQB694 route compound structure diagram
    ACEOQB69490748-01-9 In Stock
  4. Then
  5. ACHFBI876 route product structure diagram
    ACHFBI876220060-39-9
Inquiry

Comments (0)